Nu Skin Enterprises (NYSE:NUS) Raised to “Buy” at StockNews.com

Nu Skin Enterprises (NYSE:NUSGet Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday.

Several other research analysts also recently commented on the company. DA Davidson cut their target price on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a report on Monday, August 12th. Citigroup cut their target price on Nu Skin Enterprises from $14.00 to $11.50 and set a “neutral” rating on the stock in a report on Friday, August 9th. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Nu Skin Enterprises presently has a consensus rating of “Hold” and an average price target of $16.50.

Get Our Latest Research Report on Nu Skin Enterprises

Nu Skin Enterprises Price Performance

Shares of NYSE NUS traded down $0.34 during mid-day trading on Friday, hitting $8.01. 699,836 shares of the stock traded hands, compared to its average volume of 745,415. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. Nu Skin Enterprises has a twelve month low of $8.00 and a twelve month high of $24.38. The company has a market cap of $397.83 million, a PE ratio of -133.50 and a beta of 1.13. The firm has a 50 day simple moving average of $10.09 and a two-hundred day simple moving average of $11.83.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The company had revenue of $439.10 million for the quarter, compared to the consensus estimate of $431.87 million. During the same quarter last year, the business posted $0.54 EPS. Nu Skin Enterprises’s revenue for the quarter was down 12.2% on a year-over-year basis. As a group, equities research analysts forecast that Nu Skin Enterprises will post 0.78 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. ProShare Advisors LLC raised its position in shares of Nu Skin Enterprises by 36.5% in the 1st quarter. ProShare Advisors LLC now owns 597,614 shares of the company’s stock worth $8,265,000 after acquiring an additional 159,831 shares in the last quarter. CWM LLC raised its position in shares of Nu Skin Enterprises by 38.4% in the 1st quarter. CWM LLC now owns 3,286 shares of the company’s stock worth $45,000 after acquiring an additional 911 shares in the last quarter. Norges Bank bought a new position in shares of Nu Skin Enterprises in the 4th quarter worth about $8,930,000. EP Wealth Advisors LLC raised its position in shares of Nu Skin Enterprises by 605.7% in the 1st quarter. EP Wealth Advisors LLC now owns 71,814 shares of the company’s stock worth $993,000 after acquiring an additional 61,638 shares in the last quarter. Finally, SteelPeak Wealth LLC bought a new position in shares of Nu Skin Enterprises in the 1st quarter worth about $207,000. 82.84% of the stock is owned by institutional investors.

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Articles

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.